All Industries

Symphony showcases its community innovations at flagship conference, including interoperability with Microsoft Teams

Symphony Communication Services

Symphony, the leading markets’ infrastructure and technology platform, will be interoperable with Microsoft Teams, it was announced at the company’s flagship event Symphony Innovate in New York on April 18th. The solution demonstrated two distinct capabilities to connect users on Symphony securely with Teams: connecting internal Teams users natively through Symphony’s directory and bi-directional chats with external contacts on WhatsApp, SMS and WeChat, through the embedded Symphony Connect app, complementing the firm’s existing video integration. Video. For the first time, Symphony showcased the power of AI when used with its Cloud9 Trader Voice product. The new generative AI-powered and AI noise-suppressed solution provides high-accuracy transcription and intelligence to voice trading interactions, extracting detailed analysis with models trained in trading floor jargon, informing strategic decisions, improving trader efficiency, and simplifying customer risk management. Through the use of AI, the solution supports deal tagging, allowing users to extract deal-related information from voice calls such as price, quantity, and asset class, to build a comprehensive, concise transaction summary. Symphony’s specialized language models are being used to identify relevant keywords, phrases, or context to mark a conversation as a deal confirmation call. Video. With the T+1 settlement cycle fast approaching, the operations directory showcased the ease of finding and connecting with peers, expediting issue resolution, and exception management on Symphony. The Depository Trust & Clearing Corporation took to the stage to help share Symphony’s embedded collaboration platform (ECP) integration with Central Trade Match (CTM), DTCC’s platform to allocate and centrally match transactions globally. This integration - currently being piloted - will allow users to communicate with counterparties directly, reducing context switching and manual data entry to streamline post-trade matching and confirmation, an important aspect of T+1. Video. Another five ECP use cases were shown on stage in a clear validation of the relevance of Symphony’s interoperability play to the industry. CEO Brad Levy said: “Innovate is the forum where Symphony’s industry-leading customers and partners get to showcase the innovations built on our platform. We are proud to be connecting people and companies in a distributed, flexible, and interoperable way, through the right tech stack and infrastructure.” He explained: “In a time where firms must choose to disrupt or be disrupted, Symphony has the right technology to drive innovation and move with precision in a time of uncertainty.” CEO keynote video. Among the industry leaders on stage showcasing the community innovations were John Hoffman from DTCC, Guilis Aquino, Ella White, and David Feldman from Citi, Afzal Memon and Kate Finlayson from JP Morgan, Mike Torregrossa from UBS, Peter Williams and Anand Gupta from Wells Fargo, Brandi Love from RBC, Nigel Someck from MDXT, Sid Bhandari from Loanbook, Omar Gazarin and Rahul Ravikrishnan from Eidosmedia, Paul Taylor from HUB, Eslam Gebriel from Goldman Sachs, Steve Surdykowski from Capital One, Mauricio Sada-Paz and Robert Mackenzie Smith from Bank of America, Sarah Schaffer from BlackRock, Venu Bolisetty and Thomas Dolan from 28Stone, Philip Slavin and Kishan Bharwad from Taskize, Miguel Ferreria from Euroclear Bank, Colin Duggin from TP ICAP, Matthew Cheung from ipushpull, and Mohamed Khalifa from JP Morgan Private Bank. Symphony’s new virtual number solution was introduced as a way for firms to provide employees with a convenient, centralized, and compliance-friendly identity for communication across mobile voice, SMS, and social messaging applications. Symphony has partnered with Umony, a telecommunications compliance specialist, to capture and archive mobile communications, while summarizing call transcripts, analyzing sentiment, and flagging compliance risks using Umony trained LLMs for true end-to-end, GenAI-powered communications compliance. Video. More than 200 leaders joined Symphony Innovate 2024 in person, and over 400 professionals globally watched live online. You can view all Innovate 2024 sessions here. More session videos: Welcome and opening RBC/MDXT NewBridge LoanBook Eidosmedia Wells Fargo HUB In Conversation: Market Structure Evolution Citi 28Stone Taskize & Euroclear Bank TPICAP & ipushpull About Symphony Symphony is the most secure and compliant markets’ infrastructure and technology platform, where solutions are built or integrated to standardize, automate and innovate financial services workflows. It is a vibrant community of over half a million financial professionals with a trusted directory and serves over 1000 institutions. Symphony is powering over 2,000 community built applications and bots. For more information, visit www.symphony.com. Contact Details Odette Maher +44 7747 420807 odette.maher@symphony.com Company Website https://symphony.com/

April 29, 2024 08:24 AM Eastern Daylight Time

New Standard of Care? IceCure Submits Final ICE3 Data To FDA, Minimally Invasive Cryoablation Shows Similar 5-year Recurrence Outcomes To Surgery With Hormone Therapy

Benzinga

By Meg Flippin, Benzinga IceCure Medical Ltd. (NASDAQ: ICCM), the Israeli medical device developer of ProSense®, an advanced liquid-nitrogen-based cryoablation therapy that destroys tumors (benign and cancerous) by freezing them, is one step closer to getting U.S. Food and Drug Administration approval to market ProSense® to treat patients with early-stage T1 invasive breast cancer with cryoablation and adjuvant hormone therapy. IceCure just reported final clinical trial results of 100% patient and physician satisfaction with the minimally invasive procedure. At the 5-year follow-up evaluation, 96.3% of the subgroup of patients treated with ProSense® cryoablation, followed by hormone therapy, were estimated to be free from local recurrence Earlier in April, the company submitted its final data to the FDA which included five-year follow-up data from its ICE3 study, a sub-analysis of the ICE3 results compared to studies that evaluated the risk of recurrence in patients with low-risk Luminal A breast cancer who were treated with lumpectomy surgery and received hormone therapy and real-world data from the use of ProSense® globally, including post-market commercial use as well as data from independent third-party studies. ProSense®, which received the FDA's Breakthrough Device Designation, is already cleared for use in the U.S. for several other indications, including treating benign tumors of the breast and tumors in the kidney and liver. Positive Topline Results IceCure’s ICE3 study was the largest controlled multicenter clinical trial ever performed for liquid nitrogen (LN2) based cryoablation of low-risk, early-stage malignant breast tumors. The five-year recurrence-free rates from the study, which evaluated IceCure's minimally invasive 20-to-40-minute outpatient cryoablation procedure, were in line with expectations and showed similar outcomes to lumpectomy, the current standard of care for early-stage breast cancer patients, which is breast surgery that requires an operating room and hospital stay. In the ICE3 study, 96.39% of patients (187 out of 194 patients) were local recurrence-free with no significant device-related adverse events or complications reported. A comparison of this result from the ICE3 study shows similar outcomes in five-year recurrence rates compared to patients in other studies who were treated with lumpectomy followed by hormone therapy. The LUMINA study reported a 97.7% recurrence-free rate at five-year follow-up and the PRISMA meta-study, which included Lumina, reported a 97.19% recurrence-free rate at five-year follow-up. ICE3 results are also in line with data from real-world use of ProSense® by third parties in territories where IceCure's cryoablation system is used to treat early-stage breast cancer. In the final ICE3 analysis, no significant device-related adverse events or complications were reported, and all patients and physicians reported satisfaction with the ProSense® procedure, the company said. That means 100% of physicians and patients were happy with the treatments they received. Dr. Richard Fine, ICE3’s lead investigator, presented final data from the ICE3 study at the American Society of Breast Surgeons 25th Annual Meeting, where he commented, "Cryoablation is a safe, minimally invasive ablative procedure with acceptably low five-year same breast recurrence similar to that of lumpectomy for similar patient populations, with the benefit of being an office-based, nonsurgical treatment. Further study within a clinical trial or registry is needed to confirm cryoablation as a viable alternative to surgical excision in the appropriately selected patients.” Dr. Fine’s presentation, which received the conference’s Scientific Impact Award, was well received by breast surgeons who are constantly looking for treatments that are minimally invasive and effective. A New Way To Treat An Old Problem What makes cryoablation so attractive to freeze and destroy tumors is that it is minimally invasive, has little pain associated with it and thanks to an ultrasound or computerized tomography can accurately destroy diseased tissue within the tumor zone. Cryoablation also costs less than a lumpectomy and reduces the risk of follow-up surgery. With a lumpectomy, the re-excision rate is between 14-21%. IceCure’s ProSense® has the potential to become a new standard of care treatment for women with early-stage T1 invasive breast cancer, marking a major improvement to the care available today. Some researchers have even called cryoablation the “ ultimate esthetic solution for breast cancer ” because it reduces the need for pre-emptive or corrective surgical procedures to maintain or restore breast volume, contour and symmetry. "Initial reimbursement codes are already in place and our U.S. marketing and commercial team is ready, as we await the FDA's response. Driven by favorable healthcare economics combined with patient satisfaction and demand, we expect rapid adoption pending FDA granting the DeNovo Classification Request for Marketing Approval," stated IceCure CEO Eyal Shamir. With Reimbursement In Place, IceCure Is Ready To Go With the final data submitted, IceCure is ready to go once the FDA gives it the green light. The company received what it said was the first Medicare coverage approval of a cryoablation procedure for breast cancer. The Centers for Medicare & Medicaid Services (CMS) set the reimbursement payment at about $3,400 for the facility alone. Additional coverage, including payment for the physician, is expected upon establishment of the permanent CPT Category I code, which is conditioned on factors including the company's receipt of FDA marketing authorization of ProSense® for breast cancer. Having that reimbursement should enhance the usage of the ProSense® system. Nearly 300,000 women are diagnosed with invasive breast cancer yearly, and the majority have to undergo invasive treatments and deal with follow-up surgeries in the quest to live cancer-free. IceCure is changing that by freezing tumors to destroy them. IceCure seems poised to do exactly what it set out to do: provide women with an alternative minimally invasive treatment option. Featured photo by Angiola Harry on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

April 29, 2024 08:20 AM Eastern Daylight Time

Image

INSIDER BUYING: Vuzix (NASDAQ: VUZI) Executives Including CEO Snap Up Shares

Benzinga

By Meg Flippin, Benzinga Vuzix Corp. (NASDAQ: VUZI), the maker of smart glasses and augmented reality (AR) products, seems to be off to a good start in 2024 with several potential big deals in the works for both its enterprise products and original equipment manufacturing projects. At the same time, the Rochester, New York-based smart glasses maker with more than 375 patents is in a judicious cost-cutting mode, reducing expenses, improving margins and extending its operational runway. "In 2023, Vuzix made important advancements in our product development, core optics technologies and manufacturing, all of which uniquely position Vuzix to play an important role in the expected to become multibillion-dollar AR smart glasses market," said Paul Travers, President and CEO of Vuzix, when reporting full-year 2023 results. “We have a good book of business with identified opportunities, representing large potential deals and cornerstone customers for our enterprise products. And on the OEM side of our business, we expect to enter into several new projects with new and existing defense and consumer product-focused customers over the course of the year.” Insider Buying Signals Confidence Travers and other executives at Vuzix believe in the company not just as employees but also as investors. They have been showing their confidence in the company’s prospects by buying up stock during the past month. When insiders, namely CEOs, buy shares of their company, it signals executives have confidence in the business and/or think the stock is undervalued. It’s something investors pay close attention to. If insiders were selling shares rather than purchasing them, it could be a red flag that something is amiss. Based on Travers’ recent share purchases, he’s confident of the value Vuzix offers. On April 18, the CEO purchased 7,500 shares at $1.34 per share for $10,062. Days later, Travers was buying more, purchasing 14,500 shares at $1.25 each, for a cost of $18, 163. All told the CEO spent $28,225 to buy 22,000 shares over a few days. Meanwhile, director Timothy Heydenreich Harned purchased 20,000 shares on April 22 at $1.31 per share, totaling $26,188. The moves on the part of the executives demonstrate leadership’s strong confidence in the company’s future. After all, if they weren’t so upbeat about the company and thus its stock’s prospects, they wouldn’t spend thousands of dollars to increase their holdings. It's worth noting that Vuzix’s executives aren’t deterred by volatility in the stock either. Travers spent $1.34 per share one day and when he saw an opportunity to acquire more again when the stock fell to $1.25 per share, he pounced on the opportunity. Winning Deals, Making Tech Inroads There seem to be many reasons for executives expressing confidence in Vuzix, given its 20-plus-year leadership position in the smart glasses market and the growth potential of that industry. Vuzix reports that it pioneered workforce AR and still continues to have the industry’s most diverse portfolio of enterprise smart glasses, with form factors ranging from lifestyle (Vuzix Z100), to sporty (Blade 2), to safety (Shield), to industrial and medical (M series). All of their AR products offer users a portable, high-quality viewing experience, and they expect their product portfolio, OEM and display system offerings to continue to diversify. They are also operating in an industry poised for more growth. The global smart glasses market is forecast to reach $13.68 billion by 2031, growing at a CAGR of 10.3% from 2024 through 2031. Vuzix’s success with customers for its existing and future technology is another reason Travers and other executives are so optimistic. Consider its Incognito™ Waveguide Technology, which effectively conceals any forward-facing content displayed on smart glasses. Vuzix waveguides are renowned for their exceptional brightness, clarity and performance. They can accommodate larger fields of view (FOVs) and are adaptable to a diverse range of form factors. These waveguides necessitate a robust display engine specifically designed for this purpose. Consequently, has engineered and introduced the world's smallest and most advanced display engine, which is about the size of a pencil eraser and has been recognized in the media as the tiniest microLED projector available. Vuzix reports it is engaged with potential customers and development partners ranging from U.S. and international defense organizations to a number of well-known brands and OEM supply companies. Orders Continue to Flow Then there are its Vuzix M400 smart glasses. The company just received additional orders for the smart glasses from a Fortune 100 global retailer that is using the glasses to support its warehousing and logistic needs. The smart glasses are being used in multiple locations globally including the U.S., Canada, Mexico and throughout Europe, the Middle East and Africa (EMEA). Vuzix reports that customers have continued to expand across an increasing number of their company locations since the start of 2024. This year is shaping up to be a busy one for Vuzix both on the enterprise and OEM fronts. So much so that executives, including CEO Travers, are buying up shares, signaling their confidence. With more news expected in the months to come, investors may want to pay close attention to what insiders do next. Featured photo by Sabri Tuzcu on Unsplash. Benzinga is a leading financial media and data provider, known for delivering accurate, timely, and actionable financial information to empower investors and traders. This post contains sponsored content. This content is for informational purposes only and is not intended to be investing advice. Contact Details Benzinga +1 877-440-9464 info@benzinga.com Company Website http://www.benzinga.com

April 29, 2024 08:15 AM Eastern Daylight Time

Image

Leading Brand in Inclusive Beauty Black Radiance Adds All-New Products to Melanin-Minded Line

Black Radiance

Black Radiance, the trusted cosmetics brand for women of color, is expanding its dedication to inclusive beauty with its latest collection of products. For over thirty years, Black Radiance has led the charge toward recognizing and celebrating the diversity of darker complexions by offering affordable, high-quality cosmetics with uncompromising color, trusted coverage, and formula innovation. As an extension of the brand's mission, Black Radiance launched four new affordable products that encourage people of color to embrace, enhance, define, and love their shade of beauty. The launches include The Pressed Powder, Beyond A Pout™ Lip Balm, Bold & Sexy™ Gel Eyeliner, and Brilliant Effects™ Eye Shadow Palette. "Embracing the diverse beauty of melanin-rich skin tones has been at the heart of Black Radiance for over thirty years,” said K. MacDonald Parris, Vice President, Marketing at Black Radiance. “With our latest collection, we continue our commitment to inclusivity, offering affordable, high-quality cosmetics that empower people of color to define and celebrate their unique shades of beauty." Essential to the brand’s complexion product line, the Pressed Powder is formulated to balance melanin-rich skin tones with a matte finish that looks fresh all day. The lightweight, pigment-rich powder is available in twelve shades, including 3 new fair to light shades to meet the diverse range of complexions among women of color. All shades are available now on Amazon and in-store at Walmart in June. Over 90% of consumers indicated skin moisture was significantly improved after applying the formula. The shea butter lip balm is infused with Vitamin E, Sodium Hyaluronate, and an exclusive blend of ten botanical oils, to prime, moisturize, soften, and condition lips. The multi-benefit lip balm comes in 5 vibrant yet sheer shades to accentuate melanated lips, including Pamper in clear, Kissable in mauve, Pucker Up in red, Luscious in plum, and the best-seller Smooches in fuchsia. Black Radiance Bold & Sexy™ Gel Eyeliner contours, shapes, and defines with custom definition. The dual-ended pencil features two waterproof formulas, a thin, tapered pencil for contouring and outlining and a thicker crayon that saturates eyelids with smudge-proof matte color that can be worn as an eye shadow. Rounding out the collection, Black Radiance expanded the Brilliant Effects™ Eye Shadow Palette collections with two new colorways: Paradise and Starstruck. Paradise features twelve pigment-rich hues inspired by an oasis of lush, evergreen gardens to define eyes with vivid imagination while Starstruck captivates attention with mesmerizing metallic shades that give eyes a sensational glow. Black Radiance is available to shop at www.blackradiancebeauty.com, Amazon, Target, Walmart, Rite-Aid, Walgreens, and CVS. For more information and updates, visit www.blackradiancebeauty.com and follow @blackradiancebeauty on social media. High res images, interviews, and media samples are available upon request. About Black Radiance: For over 30 years, Black Radiance® has recognized, represented, and celebrated the diversity of darker complexions by offering affordable, high-quality cosmetics with uncompromising color, trusted coverage, and formula innovation. Black Radiance empowers and inspires women of color through cosmetics, beauty, and lifestyles. Our mission – to enable Black women worldwide to be even more beautiful. We promise to create both products and experiences that encourage women of color worldwide to embrace, enhance, define, and love their shade of beauty. Contact Details Six One Agency Cami Carlson camryn@six-one.com

April 29, 2024 08:03 AM Eastern Daylight Time

Image

VIVOPOWER ANNOUNCES SALE OF AUSTRALIAN CRITICAL POWER BUSINESS UNIT

VivoPower International PLC

VivoPower International PLC (Nasdaq: VVPR, "VivoPower” or the "Company”) is pleased to announce that it has entered into a definitive asset sale agreement for the sale of one of its non-core business units, Kenshaw Electrical (“Kenshaw”), to ARA Group Limited (“ARA”), a leading diversified industrial services group based in Australia. This is in line with VivoPower’s previously announced strategy to focus on reinvesting in its strong growth businesses including Tembo. Pursuant to the terms of the asset sale agreement, VivoPower will receive approximately A$5.0m in total consideration, subject to final net working capital adjustments. The asset sale agreement is subject to customary conditions and is expected to complete on July 1, 2024. VivoPower was advised on this transaction by STS Capital Partners in Singapore. About VivoPower VivoPower is an award-winning global sustainable energy solutions B Corporation company focused on electric solutions for customised and ruggedised fleet applications, battery and microgrids, solar and critical power technology and services. The Company’s core purpose is to provide its customers with turnkey decarbonisation solutions that enable them to move toward net-zero carbon status. VivoPower has operations and personnel in Australia, Canada, the Netherlands, the United Kingdom, the United States, the Philippines, and the United Arab Emirates. Forward-Looking Statements This communication includes certain statements that may constitute “forward-looking statements” for purposes of the U.S. federal securities laws. Forward-looking statements include, but are not limited to, statements that refer to projections, forecasts or other characterisations of future events or circumstances, including any underlying assumptions. The words “anticipate,” “believe,” “continue,” “could,” “estimate,” “expect,” “intends,” “may,” “might,” “plan,” “possible,” “potential,” “predict,” “project,” “should,” “would” and similar expressions may identify forward-looking statements, but the absence of these words does not mean that a statement is not forward-looking. Forward-looking statements may include, for example, the anticipated impact that the events or transactions described in this communication may have on the Company and the expected returns therefrom. These statements are based on VivoPower’s management’s current expectations or beliefs and are subject to risk, uncertainty, and changes in circumstances. Actual results may vary materially from those expressed or implied by the statements herein due to changes in economic, business, competitive and/or regulatory factors, and other risks and uncertainties affecting the operation of VivoPower’s business. These risks, uncertainties and contingencies include changes in business conditions, fluctuations in customer demand, changes in accounting interpretations, management of rapid growth, intensity of competition from other providers of products and services, changes in general economic conditions, geopolitical events and regulatory changes, expectations on funding from investors or M&A, and other factors set forth in VivoPower’s filings with the United States Securities and Exchange Commission. The information set forth herein should be read in light of such risks. VivoPower is under no obligation to, and expressly disclaims any obligation to, update or alter its forward-looking statements whether as a result of new information, future events, changes in assumptions or otherwise. Contact Details Shareholder Enquiries shareholders@vivopower.com Company Website https://vivopower.com/

April 29, 2024 07:30 AM Eastern Daylight Time

Total Active Hub Partners with Cleo to Enhance Rewards Engine with Blockchain Technology

Plato AI

London, April 29th, 2024 - (PlatoAI via 500NewsWire) -- Total Active Hub, a leader in workplace wellbeing solutions, is excited to announce a strategic partnership with Cleo, a pioneering real world assets (RWA) technology platform. This collaboration marks a significant enhancement to Total Active Hub's rewards engine, integrating Cleo’s blockchain technology to offer a broader range of incentives and creating a more transparent, immutable rewards system. Total Active Hub is renowned for empowering organisations with adaptable physical wellbeing solutions. By facilitating employee movement programs and team-building events, Total Active Hub helps workplaces prioritise physical health as a fundamental aspect of corporate culture. Recognizing the challenges of modern workplace environments, where 1 in 4 adults globally fails to meet the minimum weekly physical activity requirements, Total Active Hub and Cleo are committed to making a substantial impact. Total Active Hub research indicates that 97% of employees are motivated to exercise more with colleagues, and 73% report being more productive throughout the day as a result of being active. Through this partnership, Total Active Hub will leverage Cleo’s innovative blockchain platform to expand its rewards offerings. Users will now have the ability to support a diverse array of causes, from tree planting to ocean plastic recovery, all aligned with the United Nations Sustainable Development Goals (SDGs). This enhancement not only broadens the scope of user engagement but also enriches the incentive mechanisms within Total Active Hub’s programs. Cleo’s technology platform is already trusted by global brands such as Mastercard, Lenovo, Google, and Hewlett Packard, and is set to feature over 100 UN SDG-backed causes by 2025. The integration with Total Active Hub’s system will bring a new level of scalability and choice to users, empowering them to support meaningful causes while improving their own health and wellbeing. Tony Eames, CEO of Total Active Hub, expressed enthusiasm about the partnership, stating, "We are thrilled to bring Cleo’s scalable and transparent blockchain solution to our users. This collaboration will not only enhance our rewards system but also allow our users to make a real difference in the world by supporting causes they truly care about." This partnership represents a transformative step for Total Active Hub as it continues to foster a culture of health and engagement across workplaces globally. By combining efforts with Cleo, Total Active Hub is set to redefine the possibilities of workplace wellbeing programs and set a new standard in the industry. Integration work starts today, and is expected to be live by the second half of 2024. For more information about Total Active Hub, please visit https://www.totalactivehub.com/. For more information about Cleo, please visit https://www.cleo.xyz About Total Active Hub: Total Active Hub is a leading provider of workplace wellbeing solutions, offering dedicated programs that encourage physical activity and team cohesion. Through its innovative platform, Total Active Hub engages numerous organisations, helping them prioritize health and improve overall workforce energy and engagement. About Cleo: Cleo is a cutting-edge RWA technology platform that enables businesses, sports entities, schools, and arts organisations to generate engagement and revenue through tokenized real-world goods. With a focus on sustainability and social impact, Cleo’s blockchain technology supports a wide range of initiatives aligned with the United Nations Sustainable Development Goals. Contact Details Bryan Feinberg +1 551-574-2169

April 29, 2024 12:00 AM Eastern Daylight Time

Image

Michael Saylor Says Bitcoin Is Refreshing; KangaMoon Announces New Partnership While Pepe Soars

Kangamoon

Recently, Michael Saylor excited the crypto community with a new Bitcoin (BTC) tweet. Meanwhile, KangaMoon (KANG) announced a major partnership with RaidSharks. Many analysts hint that this Stage 5 presale star may become the next $0.5 meme coin in 2024. Another meme coin making headlines is Pepe (PEPE), recently listed on Coinbase. Michael Saylor With a Bullish Bitcoin Statement Bitcoin (BTC) has been making waves in the crypto market. Over the last week alone, the price of BTC increased from $63,785 to $64,431. The Bitcoin market cap surged from $1.26T to $1.28T during that time. The former CEO of MicroStrategy, Michael Saylor, stated that Bitcoin is refreshing. Many Bitcoin traders commented on this tweet and agreed with this statement. This Bitcoin news may cause a rally for this crypto. Regarding its technical analysis, over 15 technical indicators are now green. Additionally, the Bitcoin crypto is trading above its 100 and 200-day EMAs. Thus, experts in the crypto field predict a potential rise to $84,321 for Bitcoin before Q2 of 2024 ends. KangaMoon (KANG): New Partnership With RaidSharks At the same time, KangaMoon (KANG) is a meme coin rapidly gaining popularity. It recently announced a significant collaboration with RaidSharks, which will help it cement its standing in the industry. With this development, KangaMoon players will experience thrilling raids and a $1,000 monthly pool. This partnership will help increase community engagement in this upcoming Play-to-Earn (P2E) game. In KangaMoon's game, KANG will serve as the primary in-game currency. With KANG, you can buy in-game items and upgrade your characters. Additionally, KangaMoon revealed it will provide all holders of this meme coin with exclusive challenges for extra rewards. Another primary focus of KangaMoon is giving back to its community. KangaMoon is now providing the most active community members with free KANG before its official launch. Thus, over 29,000 registered community members are now rushing to like and share KangaMoon's social media content. This meme coin is currently in Stage 5 of its presale, which has raised over $5.8M and is on pace to hit $6M before April 2024 ends. One KANG now costs only $0.0196 - a 290% rise from its starting price. Experts are bullish, given its ties to the P2E gaming market, which may reach $885M by 2028. They forecast a jump to $0.5 once a Tier-1 CEX lists KANG in Q2 of 2024. Pepe (PEPE): Now Trading on Coinbase After encountering technical issues, Coinbase announced that the Pepe (PEPE) perpetual futures contracts are now in full-trading mode. After this bullish Pepe news, its value soared from $0.0000051 to $0.0000078 on the 1-week chart. This meme coin's market cap increased from $2.17B to $3.28B during that time. Not only that, but the Pepe coin is now trading above its 21- and 50-day EMAs. For these reasons, prominent market analysts predict that the Pepe crypto will reach a value of $0.0042 before the end of Q2 2024. This makes Pepe one of the meme coins to watch this year. Bitcoin vs. KangaMoon vs. Pepe - Which One Can Pump First? In this crypto battle, KangaMoon emerges as the victor with a low market cap of $19.6M. This means KANG needs fewer new funds for its price to rise compared to Bitcoin and Pepe. Thus, KangaMoon is one of the most promising meme coins to watch. If interested, sign up for its presale below and obtain a 10% bonus. Discover the Exciting Opportunities of the KangaMoon (KANG) Presale Today! Website: https://Kangamoon.com/ Join Our Telegram Community: https://t.me/Kangamoonofficial Integrating GameFi and Play To EarnEmbark on your quest for glory. Assemble your champions, engage in epic battles or bet on your favorite fighters to earn $KANG tokens and exclusive rewards. Gain control of rare NFTs, unlock exclusive content and build alliances with fellow gamers as you ascend the ranks and leaderboards. Contact Details Kangamoon marketing@kangamoon.com Company Website https://kangamoon.com/

April 28, 2024 02:18 PM Central Daylight Time

Image

AI Frontiers in Healthcare: Revolutionizing Medicine at the 2024 1ArtificialIntelligence Global Conference

1BusinessWorld

As the healthcare sector undergoes a technological transformation, artificial intelligence (AI) is at the forefront, driving significant advancements. The 1ArtificialIntelligence | 2024 Global AI Conference will delve into these developments during its standout session, " Breaking New Ground: How AI and Tech Startups Are Revolutionizing the Digital Health Landscape. " Scheduled for May 9, this pivotal discussion promises to highlight the innovative role of AI in reshaping healthcare delivery and management. Moderated by Sally Ann Frank, Worldwide Lead for Health & Life Sciences, Microsoft for Startups, this panel brings together industry luminaries who are pioneering the integration of AI into healthcare. The session features: - Sally Ann Frank, WW Lead, Health & Life Sciences, Microsoft for Startups - Stead Burwell, Founder & CEO, Outbound AI - Lana Feng, Co-founder and CEO, Huma.Al - Andrew Gostine, CEO, Artisight - Ankur Teredesai, CEO, CueZen These experts are set to discuss the transformative impact of AI across various aspects of healthcare: - AI-Driven Diagnostics and Personalized Treatment: The panel will explore how AI is enhancing diagnostic accuracy and enabling personalized treatment plans that are tailored to individual patient needs. - Operational Efficiency: Insights will be shared on how AI is streamlining operations within healthcare facilities, from administrative processes to patient care, reducing costs and improving service delivery. - Ethical and Regulatory Frameworks: As AI becomes more entrenched in healthcare, the panelists will tackle the ethical considerations and regulatory challenges that need to be navigated to ensure responsible deployment of AI technologies. The discussion is not just about what AI is currently achieving but also about its future potential. The panelists will provide forecasts on emerging technologies, anticipated regulatory developments, and the long-term implications of AI in healthcare. This session will serve as a comprehensive guide for healthcare professionals, technology innovators, and policymakers interested in the intersection of AI and healthcare. For those looking to stay at the cutting edge of healthcare innovation, the "Breaking New Ground" session at the 1ArtificialIntelligence | 2024 Global AI Conference is an unmissable event. It offers a unique opportunity to hear from the trailblazers who are not only navigating the challenges of AI integration but are also setting the stage for the next generation of healthcare solutions. Contact Details Media Enquiries +1 212-220-6677 info@1businessworld.com Company Website https://1businessworld.com

April 28, 2024 03:17 PM Eastern Daylight Time

Image

News Release

BloFin Sponsors TOKEN2049 Dubai and Celebrates the SideEvent: WhalesNight AfterParty 2024

BloFin

A Glittering Moment: BloFin Shines at TOKEN2049 BloFin, a fastest-growing exchange platform, proudly announces its platinum sponsorship of TOKEN2049 Dubai and its exclusive SideEvent: WhalesNight AfterParty 2024. Following our previous role as the Gold Sponsor at TOKEN2049 Singapore, the BloFin team, now the Platinum Sponsor of TOKEN2049, continues to shine on this stage with its enthusiasm and original dedication to contributing to the cryptocurrency industry. BloFin successfully sponsored TOKEN2049 Dubai, which witnessed an extraordinary gathering of industry leaders, enthusiasts, KOLs, and innovators. Blofin’s participation in this prestigious event not only reaffirmed its commitment to fostering innovation within the blockchain ecosystem but also demonstrated its dedication to driving industry development forward. An Unforgettable Night: WhalesNight AfterParty 2024 As part of the conference, BloFin hosted the highly anticipated WhalesNight AfterParty 2024, promising an unforgettable evening of networking and celebration. Gratitude in Spotlight: Heartfelt Thanks to Valued Partners and Media BloFin extends its gratitude to its esteemed media partners, including U.Today, BeInCrypto, CoinTelegraph MENA, Crypto.news and Chainwire, whose support has been instrumental in promoting this event. Additionally, BloFin appreciates the steadfast support and participation of its significant partners, KOLs, and attendees. The Dubai Whales Night offers the BloFin team a valuable opportunity to meet with users and friends. Matt, CEO of BloFin, shared his insights and expressed his excitement at the WhalesNight AfterParty. He stated “We understand the importance of trust. We will continue to provide our users with safe, reliable, and fast services.” As we continue to expand our reach and enhance our offerings, Blofin remains steadfast in its mission to empower individuals and institutions to unlock the full potential of blockchain technology. About BloFin: As the fastest-growing crypto exchange, BloFin offers premium perps & futures trading services with over 320 USDT-M trading pairs and 100X trading volume. Now, it provides more high-quality products including spot trading, copy trading, earning, API access, and more. Ensuring utmost user fund security, BloFin has partnered with Fireblocks to safeguard users’ assets. Contact Details BloFin Annio Wu annio@blofin.io

April 28, 2024 12:32 PM Eastern Daylight Time

1 2 3 4 5 ... 3460

Back